This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
The economic costs of Crohn’s disease and ulcerative colitis
The Economic Costs of Crohn’s Disease and Ulcerative Colitis landmark 2007 study commissioned by CCA and conducted by Deloitte Access Economics revealed the (then) $2.7 billion annual cost of Crohn’s disease and ulcerative colitis in Australia.
The report detailed the financial costs and economic burden caused by these chronic illnesses.
The study also recommends a strategy to reduce the costs associated with IBD and enhance the quality and options for care and disease management.